Phibro Animal Health | PAHC - Spese Di Vendita E Di Amministrazione





Spese Di Vendita E Di Amministrazione Cambiamento Data
Align Technology USD 465.34M 23.67M 2026-03
ANI Pharmaceuticals USD 73.66M 9.14M 2026-03
Assertio Holdings USD 16.73M 1.66M 2024-09
Aurora Cannabis CAD 40.62M 1.17M 2025-12
Bristol-Myers Squibb USD 1.62B 564M 2026-03
Canopy Growth CAD 28.9M 636K 2025-12
Corcept Therapeutics USD 128.04M 13.3M 2026-03
Eli Lilly USD 2.93B 198M 2026-03
Henry Schein USD 809M 1000K 2026-03
Idexx Laboratories USD 299.85M 24.18M 2026-03
Knight Therapeutics CAD 35.45M 4.43M 2025-12
Merck USD 2.67B 180M 2026-03
Nektar Therapeutics USD 10.17M 10.17M 2025-12
Pacira USD 83.88M 7.99M 2026-03
Phibro Animal Health USD 78.32M 10.24M 2025-12
Prestige Brands USD 30.28M 606K 2026-03
Supernus Pharmaceuticals USD 118.23M 4.16M 2026-03
Zoetis USD 588M 31M 2026-03